OQ

Mexico's Historic Extradition of Drug Lords Amid Trump’s Pressure

1 month ago

In a striking move that underscores the precarious relations between Mexico and the United States regarding drug trafficking, Mexican authorities have extradited notorious drug lord Rafael Caro Quintero along with several other high-profile traffickers. This bold decision comes in the wake of former President Donald Trump's fierce demands for a more aggressive stance on drug-related crime in Mexico, aimed at curbing the growing fentanyl crisis gripping the United States.

AbbVie Reports Surge in New Drug Sales Offsetting Humira's Decline

2 months ago

In a significant financial update, AbbVie Inc. has announced that its recent introduction of new medications is helping to mitigate the revenue losses resulting from the declining sales of its blockbuster drug, Humira. As a leader in the biopharmaceutical industry, AbbVie is navigating a pivotal transformation as it evolves beyond Humira, a drug that has been a cornerstone of its revenue for years.

Oman's OQ Aims High with $490 Million Methanol Unit IPO

5 months ago

OQ, Oman’s state-backed energy firm, is setting its sights on a significant financial boost through an initial public offering (IPO) related to its methanol production unit. The company is looking to raise an impressive $490 million in the transaction, which underscores a growing trend in the energy sector of capitalizing on potential market opportunities.

AbbVie Raises Profit Outlook as Rinvoq and Skyrizi Outperform Expectations

5 months ago

In a significant update from the biopharmaceutical giant AbbVie, the company has revised its profit expectations upward following strong performance from its inflammatory drugs, Rinvoq and Skyrizi. This development, reported on October 30, 2024, signals a promising trend in AbbVie's growth strategy and showcases the resilience of its product pipeline amidst a competitive market landscape.